DK71686A - VACCINE AGAINST DISEASES CAUSED BY MICROORGANISMS, SUCH AS MYCOPLASMS, ITS MANUFACTURING AND MICROORGANISM MEMBRANES AS ACTIVE PRINCIPLE - Google Patents

VACCINE AGAINST DISEASES CAUSED BY MICROORGANISMS, SUCH AS MYCOPLASMS, ITS MANUFACTURING AND MICROORGANISM MEMBRANES AS ACTIVE PRINCIPLE Download PDF

Info

Publication number
DK71686A
DK71686A DK71686A DK71686A DK71686A DK 71686 A DK71686 A DK 71686A DK 71686 A DK71686 A DK 71686A DK 71686 A DK71686 A DK 71686A DK 71686 A DK71686 A DK 71686A
Authority
DK
Denmark
Prior art keywords
microorganisms
membranes
active principle
diseases caused
vaccine
Prior art date
Application number
DK71686A
Other languages
Danish (da)
Other versions
DK162509B (en
DK162509C (en
DK71686D0 (en
Inventor
Marylene Kobisch
Laurence Quillien
Henri Wroblewski
Original Assignee
Centre Nat Rech Scient
Department Des Cotes Du Nord
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Department Des Cotes Du Nord filed Critical Centre Nat Rech Scient
Publication of DK71686D0 publication Critical patent/DK71686D0/en
Publication of DK71686A publication Critical patent/DK71686A/en
Publication of DK162509B publication Critical patent/DK162509B/en
Application granted granted Critical
Publication of DK162509C publication Critical patent/DK162509C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

A vaccine for protecting against diseases caused by microorganisms which have a membrane as the outermost envelope, in particular a mycoplasma, characterized in that it contains, as the active principle, plasma membranes from the microorganisms in question, which membranes are at least to a large extent free of the other constituents of the microorganisms. The vaccine is prepared by culturing the microorganisms in question, collecting and lysing the cells in an ultrasonic process and sedimenting the membranes by centrifugation and bringing them into a form which is suitable for vaccination. When the active principle consists of membranes from Mycoplasma hyopneumoniae, the vaccine provides, when administered subcutaneously and/or intramuscularly, efficient protection of pigs and the litters of pregnant sows against enzootic pneumonia.
DK071686A 1984-06-15 1986-02-14 VACCINE FOR DISEASES CAUSED BY MYCOPLASMS, ITS MANUFACTURING AND MYCOPLASMA MEMBRANES AS ACTIVE PRINCIPLE DK162509C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8409422A FR2565825B1 (en) 1984-06-15 1984-06-15 VACCINE AGAINST DISEASES DUE TO MICROORGANISMS SUCH AS MYCOPLASMS, PREPARATION THEREOF AND MEMBRANES OF MICROORGANISMS AS ACTIVE INGREDIENT
FR8409422 1984-06-15
PCT/FR1985/000152 WO1986000019A1 (en) 1984-06-15 1985-06-14 Vaccine against diseases due to micro-organisms such as mycoplasms, preparation thereof and membranes of micro-organisms as active principle
FR8500152 1985-06-14

Publications (4)

Publication Number Publication Date
DK71686D0 DK71686D0 (en) 1986-02-14
DK71686A true DK71686A (en) 1986-02-14
DK162509B DK162509B (en) 1991-11-11
DK162509C DK162509C (en) 1992-03-30

Family

ID=9305083

Family Applications (1)

Application Number Title Priority Date Filing Date
DK071686A DK162509C (en) 1984-06-15 1986-02-14 VACCINE FOR DISEASES CAUSED BY MYCOPLASMS, ITS MANUFACTURING AND MYCOPLASMA MEMBRANES AS ACTIVE PRINCIPLE

Country Status (6)

Country Link
EP (1) EP0185042B1 (en)
JP (1) JPS61502466A (en)
DE (1) DE3574109D1 (en)
DK (1) DK162509C (en)
FR (1) FR2565825B1 (en)
WO (1) WO1986000019A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208550B (en) * 1986-07-25 1993-11-29 Synergen Inc Process for producing polypeptides with recombinant dns technic for diagnostizing micoplasmic infections of pigs
EP0283840A3 (en) * 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
GB8709803D0 (en) * 1987-04-24 1987-05-28 Mcfadden J J Treatment of crohn's disease &c
US5225324A (en) * 1987-04-24 1993-07-06 Bioscience International, Inc. Diagnostics for mycobacteria in public health, medical, and veterinary practice
US4985243A (en) * 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US4873937A (en) * 1988-01-28 1989-10-17 Nordson Corporation Method and apparatus for spraying powder into a continuous tow
DE3809796A1 (en) * 1988-03-23 1989-10-05 Wolfgang Prof Dr Med Bredt PROCESS FOR CLEANING A 168 KD PROTEIN OF MYCOPLASMA PNEUMONIAE
ATE134705T1 (en) * 1988-06-29 1996-03-15 Ml Technology Ventures RECOMBINANT HYOPNEUMONIAE ANTIGEN AND USE THEREOF
WO1990007935A1 (en) * 1989-01-23 1990-07-26 Auspharm International Ltd. Vaccine composition
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US7943352B2 (en) * 2006-03-29 2011-05-17 Bacoustics, Llc Apparatus and methods for vaccine development using ultrasound technology
ITFI20060163A1 (en) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa PHARMACEUTICAL COMPOSITION CONTAINING A MONOCLONAL ANTI-IDIOTIC ANTI-CA-125 AND ALUMINUM ANTIBODY
KR101225304B1 (en) 2007-11-06 2013-01-22 와이어쓰 엘엘씨 Mycoplasma hyopneumoniae avirulent-adjuvanted live vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5540568B2 (en) * 1972-10-05 1980-10-18

Also Published As

Publication number Publication date
DK162509B (en) 1991-11-11
JPS61502466A (en) 1986-10-30
WO1986000019A1 (en) 1986-01-03
DK162509C (en) 1992-03-30
EP0185042A1 (en) 1986-06-25
FR2565825B1 (en) 1990-07-13
FR2565825A1 (en) 1985-12-20
DK71686D0 (en) 1986-02-14
DE3574109D1 (en) 1989-12-14
EP0185042B1 (en) 1989-11-08

Similar Documents

Publication Publication Date Title
DK71686A (en) VACCINE AGAINST DISEASES CAUSED BY MICROORGANISMS, SUCH AS MYCOPLASMS, ITS MANUFACTURING AND MICROORGANISM MEMBRANES AS ACTIVE PRINCIPLE
Amano et al. Deficiency of peptidoglycan and lipopolysaccharide components in Rickettsia tsutsugamushi
EP0047662B1 (en) Coccidiosis vaccines
Stewart et al. Importance of pilus-associated antigen in Bacteroides nodosus vaccines
EP0068660B1 (en) Protection against dental caries
DZ634A1 (en) Non-toxigenic vibrio cholera mutants.
ES2121841T3 (en) A VACCINE TO PROVIDE IMMUNOLOGICAL PROTECTION AGAINST ROTAVIRUS DISEASES IN HUMANS.
AU1463097A (en) Helicobacter pylori bacterioferritin
KR940004541B1 (en) Treponema hyodysenteriae bacterin and process for preparing thereof
AU5329279A (en) Feline infectious peritonitis vaccine
Singh et al. Therapeutic Effects of a New “Indigenous Vaccine” Developed Using Novel Native “Indian Bison Type” Genotype of Mycobacterium avium Subspecies paratuberculosis for the Control of Clinical Johne′ s Disease in Naturally Infected Goatherds in India
EP0015846B1 (en) Antigenic sub-cellular cell wall fraction of bordetella bronchiseptica, method of obtaining it and composition comprising it
IE810618L (en) Pasteurella vaccines
WO2001049821A3 (en) Th1 specific cd4 t cell lines and method for inducing them ex vivo
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
AU3532089A (en) A pasteurella vaccine
CA2172180A1 (en) A multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
GB1569003A (en) Immunostimulating agent
Groschup et al. Modified Feist broth as a serum-free alternative for enhanced production of protective antigen of Erysipelothrix rhusiopathiae
Elad et al. Immunogenicity in calves of a crude ribosomal fraction of Trichophyton verrucosum: a field trial
US5110589A (en) Swine dysentery subunit vaccine and method
Kohashi et al. Arthritogenicity in rats of cell walls from several streptococci staphylococci and two other bacteria
US4248862A (en) Immunogenic cell envelope preparations
Lehner et al. Attempted immunisation of laboratory animals with metabolic antigens of Fasciola hepatica
Krasse et al. Effect of orally applied vaccines on oral colonization by Streptococcus mutans in rodents

Legal Events

Date Code Title Description
PUP Patent expired